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Abstract
Fluorescent protein (FP) biosensors based on Fo¨rster resonance energy transfer (FRET)
are commonly used to study molecular processes in living cells. There are FP-FRET biosen-
sors for many cellular molecules, but it remains difficult to perform simultaneous measure-
ments of multiple biosensors. The overlapping emission spectra of the commonly used FPs,
including CFP/YFP and GFP/RFP make dual FRET measurements challenging. In addition,
a snapshot imaging modality is required for simultaneous imaging. The Image Mapping
Spectrometer (IMS) is a snapshot hyperspectral imaging system that collects high resolu-
tion spectral data and can be used to overcome these challenges. We have previously dem-
onstrated the IMS’s capabilities for simultaneously imaging GFP and CFP/YFP-based
biosensors in pancreatic β-cells. Here, we demonstrate a further capability of the IMS to
image simultaneously two FRET biosensors with a single excitation band, one for cAMP
and the other for Caspase-3. We use these measurements to measure simultaneously
cAMP signaling and Caspase-3 activation in pancreatic β-cells during oxidative stress and
hyperglycemia, which are essential components in the pathology of diabetes.
Introduction
Spectral imaging techniques can be powerful tools for fluorescent protein (FP) imaging of liv-
ing cells. Biosensors that rely on intramolecular Fo¨rster resonance energy transfer (FRET) are
commonly used as probes for biological function [1]. Many FRET-based biosensors contain a
cyan fluorescent protein (CFP) variant donor and a yellow fluorescent protein (YFP) variant
acceptor [2]. Despite the creation of an efficient green/red FRET pair [3], dual-FRET remains
challenging due to the overlapping emission spectra of the FPs. Fluorescence lifetime imaging
microscopy (FLIM) has been used for dual-FRET applications [4], but FLIM offers limited
temporal resolution (> 10 sec), so it is too slow to reveal relationships between many sequen-
tial signaling pathways and rapid changes in cellular response to stimuli. Hyperspectral meth-
ods allow for the collection of the entire fluorescence emission spectrum at each pixel in an
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image, thus providing a means of quantitative imaging of multiple probes in a single experi-
ment [5,6]. In principle, these approaches are well-suited for dual-FRET imaging, but most
hyperspectral imaging methods rely on sequential image acquisitions that are incompatible
with truly simultaneous multi-color imaging. Furthermore, the data analysis is challenging, as
quantitation of hyperspectral FRET experiments relies upon reference spectra, high quality
data and spectral resolution [7]. Finally, most multispectral imaging systems use sequential
scanning either in space or wavelength, which requires increased illumination times [8,9].
Thus, these methods are limited in spectral and/or temporal resolution and lack sufficient
dynamic range for quantifying the small changes measured by most FRET-based biosensors.
An alternative hyperspectral imaging approach that addresses many of these challenges is
the Image Mapping Spectrometer (IMS). The IMS is a camera-based snapshot hyperspectral
imaging system that allows rapid collection of high-resolution spatial and spectral data in a sin-
gle snapshot with a single excitation source. When coupled to a wide-field microscope, the
IMS does not require sequential scanning in space or wavelength and has an image acquisition
rate tha tis limited only be the camera speed or signal intensity. In the system described here,
the camera used provides a large field-of-view (225 x 240 μm) with acquisition rates up to 7.2
frames per second. The IMS uses an image mapper that spatially distributes neighboring pixels
in the intermediate image to create blank regions in the final image. The spectral content of
each pixel is then dispersed into these blank regions so that the final image is mapped onto a
2D detector array where each pixel represents a unique x, y, λ value. This method allows paral-
lel measurement of a sample’s x, y, λ datacube without scanning, thus collecting the whole
datacube in a single snapshot with high optical throughput [10]. The widefield IMS used here
collects data within a spectral window from 450 nm to 650 nm with ~4 nm sampling interval,
which is sufficient for differentiating commonly overlapping fluorophores, such as CFP, GFP,
and YFP. We have previously demonstrated that the IMS coupled to a widefield microscope is
useful for simultaneously studying time-resolved cAMP and Ca2+ signaling dynamics in pan-
creatic β-cells [11]. This was accomplished with biosensors for cAMP, a cyan/yellow FRET
sensor (T-Epac-VV) [12], and a cpGFP-based Ca2+ sensor [13] with overlapping spectra. This
work verified that the IMS can effectively separate spectra with differences greater than two
spectral bins (in this case> 8 nm), as expected from Nyquist sampling theory. Another recent
configuration of the IMS coupled to a smaller but faster sCMOS camera and a light-sheet
microscope demonstrated the measurement of Ca2+ and Zn2+ in different populations of cells
in intact tissue [14].
To test the IMS for dual-FRET imaging in the widefield configuration, we investigated the
effects of oxidative stress and hyperglycemia on cAMP signaling while monitoring Caspase-
3-mediated apoptosis in cultured MIN6 pancreatic β-cells. These experiments used an estab-
lished cAMP biosensor [12], and a newly prepared Caspase-3 cleavable biosensor (GRSCAT)
with the green/red FRET pair mClover and mRuby2 [3]. Dysregulated β-cell apoptosis contrib-
utes to the development of type 2 diabetes and limits the effectiveness of islet transplantation
therapy for patients with type 1 diabetes [15–17]. However, few tools are available to measure
the process of apoptosis in live-cell experiments, which limits the ability to determine the cellu-
lar processes that are important for inducing β-cell death. The GRSCAT sensor presented here
is an intramolecular FRET-based probe built with a Caspase-3 cleavage site between the mClo-
ver and mRuby2 FPs [3], and provides a live measure of apoptosis induction.
The generation of reactive oxygen species (ROS) is an important route by which β-cell apo-
ptosis is stimulated during diabetes, though little is known about the molecular mechanism
that drives it. Several G-protein coupled receptors are critical regulators of β-cell function and
are known to proceed via cAMP, so we took advantage of the sensors that we had available to
probe this signaling pathway. It has been shown that NADPH oxidase reduces cAMP/PKA
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signaling secondarily to ROS generation and reduces insulin secretion, suggesting that cAMP
signaling is redox-responsive [18]. Another study showed that increasing cAMP levels led to
increases in c-myc expression that drove Caspase-3 activation and apoptosis, though in the
absence of oxidative stress [19]. These data suggest a possible role for cAMP signaling in apo-
ptosis, but provide different mechanistic explanations for it depending on the redox state of
the β-cells. Thus, the molecular mechanisms underlying ROS generation during oxidative
stress and hyperglycemia and the subsequent effect on apoptosis remain unclear.
Here, we develop a dual-FRET approach to measure simultaneously cAMP and Caspase-3
activity, using a novel Caspase-3 biosensor. We validate the quantitative separation of these
two signals using a single excitation band and hyper-spectral imaging by IMS. We show the
use of this new quantitative dual-FRET IMS approach to measure functional dynamics in
MIN6 pancreatic β-cells. We treat the cells with high glucose and/or hydrogen peroxide to
dynamically interrogate the relationship between cAMP signaling and mitochondria-mediated
apoptosis, via Caspase-3 activation. By selectively inducing hyperglycemia and oxidative stress,
we measured the relationship between these states in an effort to better understand cellular sig-
naling mechanisms in β-cell death.
Materials and methods
Biosensors
A green-red FRET pair version of the SCAT3.1 biosensor [20] was created by direct replace-
ment of CFP with mClover [5] and YFP with mRuby2 [3]. The resulting green-red FRET bio-
sensor is referred to as green-red SCAT, or GRSCAT. The cyan/yellow FRET cAMP biosensor
(T-Epac-VV) from the Jalink lab, mTurqDel-EPAC(dDEPCD)-cp173Venus(d)-Venus(d)(H74)
was used as published with no further modifications [12]. Both sensors respond to increases in
target molecules (cAMP and Caspase-3) with a decrease in FRET ratio.
Cellular sample preparation
MIN6 cells (generous gift of R. Stein, also available from AddexBio, San Diego, CA) were tran-
siently transfected with plasmid DNA encoding GRSCAT, and/or T-Epac-VV. Transfection
was accomplished using Lipofectamine2000 (Invitrogen, Carlsbad, CA) reagent according to
the manufacturer’s instructions. Cells were seeded onto coverglass-bottomed dishes (Mat-
Tek) and cultured as previously described [21] for microscopy studies in DMEM with 11 mM
glucose. Before imaging, cells were switched to the glucose concentration for imaging (5 mM
or 20 mM) for three hours prior to imaging. Oxidative stress was induced by replacing the
media with similar media containing 30% hydrogen peroxide prior to imaging. cAMP was
increased with 50 μM Forskolin (Fsk) and 100 μM IBMX. Caspase-3 was stimulated indepen-
dently of cAMP with 1 μM Staurosporine (STS).
Time-lapse hyperspectral imaging
Hyperspectral fluorescence imaging experiments were performed on a Nikon inverted micro-
scope TE300 with a 40×/1.0 CFI Plan Apochromat oil objective. The final pixel size in the IMS
image corresponds to an object size of 0.7 μm, and an image size of 320 x 340 pixels. The cells
were placed in extracellular-like buffer (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 5 mM glu-
cose and 20 mM Hepes, pH 7.4), and epi-illuminated by a 75W Xenon lamp. A Chroma filter
set (ex: BP 436/20, bs: DCLP455, em: HQ470LP) was used to separate fluorescence emission
from excitation light. Both FRET pairs were excited by illumination through this single 436/20
bandpass filter. The intermediate image formed at the microscope side image port is directed
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to the entrance port of the IMS. The hyperspectral images were captured by the IMS and pro-
cessed in MatLab for remapping and linear spectral unmixing [22], which separated signals
from mTurquoise, cpVenus-Venus, mClover, and mRuby2 based on their spectral profiles and
generated time-lapsed intensity changes for all expressed biosensors. Rolling ball background
subtraction (radius 50 pixels) and fluorescence intensity measurement were performed using
ImageJ, and GraphPad Prism was used for statistics. Data are normalized to control samples
that were imaged at 5mM glucose.
Results
Spectral unmixing of two FRET biosensors
IMS-widefield microscopy provides a platform for rapid, simultaneous, multi-color live cell
imaging. We co-expressed cAMP and Caspase-3 biosensors in MIN6 cultured pancreatic β-
cells, yielding a four-color sample that offers the opportunity to study cellular signaling
dynamics during hyperglycemia and oxidative stress. Reference spectra were collected from
cells expressing individual FP components (mClover, mRuby2, mTurquoise, and mVenus-
mVenus constructs) and used for unmixing [22]. Fig 1 shows a representative sample of cells
expressing both FRET biosensors after linear unmixing. We previously demonstrated that the
IMS system reliably separates the two donor FPs, mTurquoise and mClover [11], so we now
wanted to show that the two FRET ratios could be deconvolved by the IMS as well.
As a first test of the functionality of the cellular system expressing both biosensors, we
treated co-expressing cells with chemicals that are expected to affect only the FRET changes
from a single biosensor. To functionally isolate the cAMP biosensor response, cells expressing
both the cAMP sensor and the Caspase-3 GRSCAT sensor were treated with IBMX/forskolin
to increase cAMP amplitudes. This treatment is expected to change cAMP levels with minimal
perturbations to Caspase-3 activity. As shown in Fig 2, IBMX/forskolin exposure (added at
t = 0) increased cAMP and high glucose elicited oscillations in the T-Epac-VV cAMP sensor
FRET ratio in 30 minutes with no significant change in the GRSCAT FRET ratio. The fungal
Fig 1. Linear unmixing two FRET biosensors. Raw intensities for the unmixed components of the FRET sensors T-Epac-VV and
GRSCAT from the circled cell are shown (left) with the RGB images of the same FOV (right) Scale bar is 20 μm.
https://doi.org/10.1371/journal.pone.0188789.g001
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toxin staurosporine (STS), which has been shown to directly and quickly activate Caspase-3
[23], was used to stimulate Caspase-3 in co-expressing cells immediately prior to imaging. Simi-
lar to the IBMX/forskolin experiments, we expected STS to lead to changes in the GRSCAT sen-
sor with little change in the cAMP biosensor. As expected, we observed a 27.3% ± 3.2 decrease
in the GRSCAT FRET ratio in 30 minutes following STS treatment with no significant change
in the cAMP sensor FRET ratio (Fig 2), as measured by area under the curve from 4–10 cells
per experiment.
Dual-FRET imaging shows anti-correlated cAMP and Caspase-3 activity
during oxidative stress and hyperglycemia
To test the efficacy of the dual-FRET IMS approach to measure changes in cellular biology, we
examined cAMP and Caspase-3 activation in hyperglycemic MIN6 cultured β-cells with or
without inducing oxidative stress. Cells were cultured for 36–72 hours post-transfection with
high glucose (11 mM). On the day of experiments, the cells were incubated for several hours
with a high glucose concentration (20 mM) to simulate hyperglycemia prior to H2O2 addition
to induce oxidative damage. Some samples were maintained at 20 mM glucose alone without
additional H2O2, and separate control samples were incubated in parallel with 5 mM glucose.
H2O2 was added to the dishes prior to imaging and baseline values were collected for the first
two minutes of data collection. Consistent with expectations for high glucose, we find that cells
pre-treated with 20 mM glucose displayed a 16.5% ± 0.54 increase in cAMP and a 20.9% ± 2.1
increase in Caspase-3 activity over low glucose controls (Fig 3), indicated by the decrease in
area under the curve. Interestingly, under the additional condition of oxidative stress, cAMP
levels were not significantly elevated over low-glucose controls (2.4% ± 3.8 increase), while
Caspase-3 activity still increased significantly (15.8% ± 5.0). A representative single cell trace is
shown in Fig 3, and the average over all cells measured under these conditions is shown in S1
Fig. To look at the relationship between the cAMP and Caspase-3 dynamics during oxidative
stress, we performed a correlation analysis of the time-resolved FRET ratios. In the presences
of high glucose alone without additional oxidative stress, we measured a non-significant posi-
tive correlation between cAMP and Caspase-3 (Fig 3; Pearson coefficient 0.3793, p = 0.0991).
Fig 2. Dual-FRET biosensor isolation by selective stimulation. Time course of Caspase-3 activation (dotted gray lines) and cAMP (solid black lines)
after stimulation with (A) IBMX/forskolin or (B) STS normalized to 5 mM glucose controls.
https://doi.org/10.1371/journal.pone.0188789.g002
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However, the addition of oxidative stress led to a significant inverse correlation between
cAMP and Caspase-3 (Fig 3; Pearson coefficient -0.5384, p = 0.0143). Taken together, these
data suggest that Caspase-3 activity and cAMP signaling are independent of each other but
inversely correlated in a redox-dependent manner during oxidative stress and hyperglycemia.
Characteristic cell shrinking and blebbing could be observed in the cells where Caspase-3
activity was high (Fig 3).
Discussion
The success of previous experiments using a widefield-coupled IMS to resolve spectrally three
fluorescent proteins during live cell imaging led us to test this system for simultaneous data
collection from two FRET-based biosensors with overlapping spectra. We utilized this system
Fig 3. Role of oxidative stress in Caspase-3 activation and cAMP generation during hyperglycemia. (A) Time course of cAMP (solid
black lines) or Caspase-3 activation (dotted black lines) for co-transfected cells treated with 20 mM glucose normalized to 5 mM glucose
controls. (B) As in (A) but with the addition of H2O2. Insets for both (A) and (B) are linear correlations with 95% confidence intervals (x-axis is
cAMP FRET ratio and y-axis is Caspase-3 FRET ratio). (C) Area under the curve for cAMP and Caspase-3 FRET measurements. These data
are from one representative cell out of 3 different dishes, each dish had N = 4–20 cells. (D) IMS images of cells treated with high glucose and
H2O2 at 0 and 90 minutes after imaging. p values were determined by ANOVA. *** indicates p < 0.001 compared to 5 mM glucose controls
for each sensor.
https://doi.org/10.1371/journal.pone.0188789.g003
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to demonstrate simultaneous dual-FRET imaging with a single excitation. The data show min-
imal measured cross-talk between the FP components for the application of cAMP signaling
and oxidative-stress induced Caspase-3 activation in pancreatic β-cells. These simultaneous
dual-FRET (four color) experiments were made possible using hyperspectral imaging com-
bined with a newly prepared green/red Caspase-3 cleavable FRET sensor and a previously-
described cyan/yellow cAMP FRET sensor.
The results presented here demonstrate the ability of the IMS approach to address complex
biological questions with high sensitivity along with excellent spatial and spectral resolution.
The widefield-IMS configuration offers a large field-of-view, allowing for the visualization and
measurement of many cells per experiment in a high-throughput format. The IMS methodol-
ogy provides a sensitive way to interrogate both signaling molecules in real-time in living
cells. Dual-FRET data presented here show that cAMP and Caspase-3 activation are inversely
correlated during oxidative stress and hyperglycemia in living cells. These data are consistent
with previous biochemistry results demonstrating that oxidative stress decreases cAMP via
NADPH oxidase production [18]. During hyperglycemia alone, we show that cAMP and Cas-
pase-3 are both increased over low-glucose controls, which confirms a redox-state dependent
relationship between these pathways.
Supporting information
S1 Fig. Dual-FRET experimental averages. Time course of Caspase-3 activation (dotted
lines) and cAMP (solid lines) after stimulation with (A) IBMX/forskolin (B) STS (C) 20 mM
glucose (D) 20 mM glucose with H2O2, normalized to 5 mM glucose controls. These data rep-
resent averages with standard deviations from cells in 3 different dishes and each dish had
N = 4–20 cells.
(TIF)
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